In our latest episode, The AI Effect on the Biopharma Market, KYBORA‘s CEO Alan Vanderborght sits down for an insightful conversation with William Compton, SVP, Digital Enabling Functions and Colleague Services at Pfizer.
Together, they explore the profound impact of AI across the industry, and what the future may hold as technology continues to rapidly evolve.
Listen below:
